Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Published:2017-12 Issue:12 Volume:15 Page:1520-1541
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:en
Short-container-title:J Natl Compr Canc Netw

Author:

Crawford Jeffrey,Becker Pamela Sue,Armitage James O.,Blayney Douglas W.,Chavez Julio,Curtin Peter,Dinner Shira,Fynan Thomas,Gojo Ivana,Griffiths Elizabeth A.,Hough Shannon,Kloth Dwight D.,Kuter David J.,Lyman Gary H.,Mably Mary,Mukherjee Sudipto,Patel Shiven,Perez Lia E.,Poust Adam,Rampal Raajit,Roy Vivek,Rugo Hope S.,Saad Ayman A.,Schwartzberg Lee S.,Shayani Sepideh,Talbott Mahsa,Vadhan-Raj Saroj,Vasu Sumithira,Wadleigh Martha,Westervelt Peter,Burns Jennifer L.,Pluchino Lenora

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer;BMC Cancer;2024-09-13

2. The long-term impact of an antimicrobial stewardship program in febrile neutropenia: an 8 years follow up;European Journal of Clinical Microbiology & Infectious Diseases;2024-09-12

3. Trends in the use of granulocyte colony stimulating factors for older patients with cancer, 2010 to 2019;Journal of Geriatric Oncology;2024-09

4. Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors—a questionnaire study;Supportive Care in Cancer;2024-05-14

5. The effect of leptin gene polymorphisms (LEP rs7799039 and LEPR rs1137101) on febrile neutropenia;Heliyon;2024-04